Citius Pharmaceuticals Inc (CTXR) stock has gained 175.31% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CTXR stock a score of 91 out of a possible 100.
That rank is influenced by a long-term technical score of 98. CTXR's rank also includes a fundamental score of 93. In addition to the average rating from Wall Street analysts, CTXR stock has a mean target price of 5. This means analysts expect the stock to increase 124.22% over the next 12 months. The short-term technical score for CTXR is 82.
What's Happening with CTXR Stock Today
Citius Pharmaceuticals Inc (CTXR) stock is lower by -4.7% while the S&P 500 has gained 0.94% as of 3:17 PM on Wednesday, Feb 24. CTXR is down -$0.11 from the previous closing price of $2.34 on volume of 24,611,264 shares. Over the past year the S&P 500 is up 25.25% while CTXR has gained 175.31%. CTXR lost -$0.47 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Citius Pharmaceuticals Inc (CTXR) Stock.
